| Megakaryocytic Neoplasm studied in …STUDIED_INderived168 of 168show fewer |
|---|
| → studied in | NCT06661915Phase 2 · recruiting A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025488Phase 1 · active not recruiting Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577926Phase 2 · active not recruiting The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361641NA · recruiting Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04285086Phase 3 · active not recruiting Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158858Phase 1/Phase 2 · completed A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612280Phase 1/Phase 2 · recruiting Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590986recruiting Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878199Phase 1/Phase 2 · terminated Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518940NA · not yet recruiting ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351631Phase 3 · recruiting A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279847Phase 1 · active not recruiting Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063486Phase 2 · recruiting Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198960Phase 3 · recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123365Phase 1/Phase 2 · recruiting An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942080NA · recruiting Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645199recruiting National Longitudinal Cohort of Hematological Diseases · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644211Phase 2 · recruiting Ruxolitinib in Thrombocythemia and Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262141Phase 2 · active not recruiting IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541249Phase 2 · recruiting MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223920Phase 2 · completed An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378437Phase 1 · recruiting A Study of GLB-001 in Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482971Phase 2 · active not recruiting A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798805active not recruiting Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083170Phase 2 · terminated Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03869476NA · completed Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734637NA · recruiting Efficacy and Safety of Peginterferon in ET and PV. · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760238recruiting Myeloproliferative Neoplasms (MPNs) Patient Registry · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897297unknown Myeloproliferative Neoplastic Diseases Observatory From Brest · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243122Phase 2 · completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218628Phase 1 · recruiting Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371573completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972943early Phase 1 · terminated CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823198Phase 1/Phase 2 · completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816256NA · completed Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03566446Phase 1 · completed CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051307Phase 1/Phase 2 · completed Dual Vaccine Trial in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124746Phase 2 · completed Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882773recruiting Asian Myeloproliferative Neoplasm (MPN) Registry · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014546Phase 1 · terminated Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369317Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530619NA · unknown Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912884completed Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121599NA · terminated 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02823184completed Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998828Phase 2 · terminated Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787552Phase 1/Phase 2 · completed A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907436NA · completed The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03745378completed Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study) · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129101Phase 1 · completed Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715247completed Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407080Phase 1 · completed Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666549completed Research Tissue Bank · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311569Phase 2 · completed Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718159Phase 1 · completed Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665067completed Correlative Biomarker Study in Patients With Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893410completed Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134120Phase 1 · completed A Study in Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970930completed Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666289completed Familial Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433862completed Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427881Phase 2 · completed Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01520220Phase 1 · completed Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076569completed Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642069completed Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146210completed Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663648withdrawn Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01243073Phase 2 · completed Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586651Phase 2 · completed Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076815Phase 3 · completed Anagrelide Retard in Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521936Phase 2 · terminated Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381550Phase 2 · completed 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668421Phase 1/Phase 2 · unknown CEP-701 (Lestaurtinib) in Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602771Phase 2 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00742625Phase 1/Phase 2 · completed Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227591Phase 2 · completed Lenalidomide and Prednisone in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039416Phase 2 · completed Imatinib Mesylate in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098423Phase 1 · completed Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470197Phase 1 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159301Phase 1 · terminated Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003190Phase 3 · completed Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006363Phase 3 · completed Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047190Phase 2 · completed Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101231Phase 1 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103272Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027872Phase 2 · completed Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816022unknown Myeloproliferative Neoplasms and Bone Structure · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095797Phase 1 · completed XK469R in Treating Patients With Refractory Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101296Phase 1 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089388Phase 2 · terminated Cilengitide in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096148Phase 2 · terminated Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002798Phase 3 · completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 168 trials mapped (33 active) | — | — | Childhood Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093418Phase 2 · completed S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112853Phase 1 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131989Phase 1 · completed Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745550Phase 1/Phase 2 · completed A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866762Phase 2 · unknown A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00522574Phase 1 · terminated A Safety Study of XL019 in Adults With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 168 trials mapped (33 active) | — | — | Adult Acute Megakaryoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |